510(k) Report

510(k) · Cleared

Cleared

Luminance Red Cold Sore Device (TN1927G)

K251973510(k) TraditionalCleared Sep 23, 202589-day reviewClass II21 CFR 878.4860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Luminance Medical Ventures, Inc. · OKJ Light Based Treatment For Cold Sores Herpes Simplex Virus-1

Cleared on Sep 23, 2025 as substantially equivalent to K222205 (Light Tree Ventures Europe B.V., 2022) after an 89-day review. Its family tree reaches back 2 generations to 2012.

Decided
Sep 23, 2025
Review
89 days
Class
Class II
Product code
OKJ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN090012 (2012). No later device cites it as a predicate yet.

  1. Root · 2 generations backDEN090012 Virulite Cold Sore MachineVirulite, LLC · 2012
  2. 1 generation backK222205 Cold Sore Device (Model: QPZ-01)Light Tree Ventures Europe B.V. · 2022
  3. This deviceK251973 Luminance Red Cold Sore Device (TN1927G)Luminance Medical Ventures, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN090012Virulite Cold Sore MachineVirulite, LLC2012—
−1K222205Cold Sore Device (Model: QPZ-01)Light Tree Ventures Europe B.V.2022—
0 (this device)K251973Luminance Red Cold Sore Device (TN1927G)Luminance Medical Ventures, Inc.2025—
FIG. 1 — Lineage of K251973, 2012–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OKJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OKJ device

  1. #1 K222205 Cold Sore Device (Model: QPZ-01)score 10.1 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K222205Cold Sore Device (Model: QPZ-01)
Summary page 5
…21 CFR 807.92(a)(3) Predicate# Predicate Trade Name (Primary Predicate is listed first) Product Code I K222205 11 Light Tree Ventures, Cold Sore Device…
Light Tree Ventures Europe B.V.2022—

Also cleared against K222205: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 10.0 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K222205.

How does its category compare?

All OKJ devices

OKJ Light Based Treatment For Cold Sores Herpes Simplex Virus-1: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · OKJ

1in 2025

2012: 12022: 12024: 12025: 1
2007high 1 (2012) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OKJ

Too few OKJ 510(k)s in any year since 2007 to give a median.

Recalls per year · OKJ

No recall names OKJ since 2007.

Adverse event reports per year · OKJ

1in 2019

2019: 1
2007high 1 (2019) · low 0 (2007)2025

MAUDE reports naming product code OKJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20121—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—01
20200—00
20210—00
20221—00
20230—00
20241—00
20251—00
20260—0—

What is it indicated for?

The Luminance Red Cold Sore device is indicated for shortening the time to healing of herpes simplex labialis lesions on and around the lips with time to healing defined as the time to patient described re-epithelialization.

This device is suitable for users with Fitzpatrick skin types I-IV.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K251973: Luminance Red Cold Sore Device (TN1927G).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K251973

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026